UT Health Science Center

Momelotinib demonstrated statistically significant improvement in anemia measures, splenic response and total symptom score compared with danzol among patients with previously treated myelofibrosis, according to study results.

Continued VB-111 monotherapy priming after progression with bevacizumab combination treatment improved survival outcomes among patients with recurrent glioblastoma, according to results of a phase 1/phase 2 study published in Neuro-Oncology.

SAN ANTONIO — A novel combination of oral paclitaxel plus encequidar significantly improved overall response rates compared with IV paclitaxel among women with metastatic breast cancer, according to results of a randomized phase 3 study presented at San Antonio Breast Cancer Symposium.

SAN ANTONIO — Detection of circulating tumor DNA after neoadjuvant chemotherapy appeared to independently predict disease recurrence among women with early-stage triple-negative breast cancer, according to preplanned analyses of results from the randomized phase 2 BRE12-158 trial presented at San Antonio Breast Cancer Symposium.

Rates of squamous cell carcinoma of the anus and related mortality have risen sharply over the past 15 years, according to results of a retrospective study published in Journal of the National Cancer Institute.

The Samuel Waxman Cancer Research Foundation awarded $1.4 million worth of new grants to fund investigations into multiple scientific areas.

AUSTIN, Texas — At the American Association of Clinical Endocrinologists Annual Scientific and Clinical Congress, Ralph A. DeFronzo, MD, BMS, MS, BS, received the American College of Endocrinology’s Distinction in Endocrinology Award.

Certain strains of gut microbiota are associated with colorectal cancer, and could be used as a non-invasive, accurate and cost-saving diagnostic test, according to new research published in Gut.

In subgroups of healthy, older men with type 2 diabetes, metformin therapy may reduce the likelihood of cardiovascular disease, cancer, depression, dementia and frailty-related diseases, although effects varied by individual risks for each condition, study findings show.

NEW ORLEANS — In this video from the National Lipid Association Scientific Sessions, John Higgins, MD, MBA, MPhil, discusses advancements in smartphone application technology and the implications for helping patients maintain a healthy lifestyle.